Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Meinian Onehealth Buys Rival China Health Testing Chain for $415 Million

publication date: Mar 8, 2016
Meinian Onehealth Healthcare, a Shanghai provider of China medical exams and disease screening, will pay $415 million to acquire the remaining 72% of a rival, Ciming Health Checkup Management. In January 2015, Meinian purchased its original 28% stake in Ciming, though it did not disclose the price. Meinian said it would issue new shares to finance the acquisition. Still pending is the contentious battle for iKang Healthcare, another China provider of medical examinations. iKang's management has offered $17.80 per ADS to take the company private, while Meinian is offering $25 per ADS, a 40% increase and a $1.5 billion valuation. More details....

Stock Symbol: (NSDQ: KANG)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital